scholarly journals Differentiation between malignant melanomas and benign melanocytic nevi by computerized DNA cytometry of imprint specimens*

1994 ◽  
Vol 21 (1) ◽  
pp. 7-15 ◽  
Author(s):  
Wilhelm Stolz ◽  
Thomas Vogt ◽  
Michael Landthaler ◽  
Siegfried Hempfer ◽  
Paul Bingler ◽  
...  
2014 ◽  
Vol 73 (2) ◽  
pp. 161-163 ◽  
Author(s):  
Ryuhei Uchiyama ◽  
Hisashi Uhara ◽  
Aya Uchiyama ◽  
Eisaku Ogawa ◽  
Yuko Takazawa ◽  
...  

eLife ◽  
2021 ◽  
Vol 10 ◽  
Author(s):  
Andrew S McNeal ◽  
Rachel L Belote ◽  
Hanlin Zeng ◽  
Marcus Urquijo ◽  
Kendra Barker ◽  
...  

Benign melanocytic nevi frequently emerge when an acquired BRAFV600E mutation triggers unchecked proliferation and subsequent arrest in melanocytes. Recent observations have challenged the role of oncogene-induced senescence in melanocytic nevus formation, necessitating investigations into alternative mechanisms for the establishment and maintenance of proliferation arrest in nevi. We compared the transcriptomes of melanocytes from healthy human skin, nevi, and melanomas arising from nevi and identified a set of microRNAs as highly expressed nevus-enriched transcripts. Two of these microRNAs—MIR211-5p and MIR328-3p—induced mitotic failure, genome duplication, and proliferation arrest in human melanocytes through convergent targeting of AURKB. We demonstrate that BRAFV600E induces a similar proliferation arrest in primary human melanocytes that is both reversible and conditional. Specifically, BRAFV600E expression stimulates either arrest or proliferation depending on the differentiation state of the melanocyte. We report genome duplication in human melanocytic nevi, reciprocal expression of AURKB and microRNAs in nevi and melanomas, and rescue of arrested human nevus cells with AURKB expression. Taken together, our data describe an alternative molecular mechanism for melanocytic nevus formation that is congruent with both experimental and clinical observations.


2016 ◽  
Vol 28 (6) ◽  
pp. 777 ◽  
Author(s):  
Ik Jun Moon ◽  
Chong Hyun Won ◽  
Mi Woo Lee ◽  
Jee Ho Choi ◽  
Sung Eun Chang

2002 ◽  
Vol 29 (6) ◽  
pp. 341-346 ◽  
Author(s):  
Emma Guttman-Yassky ◽  
Reuven Bergman ◽  
Lena Manov ◽  
Eli Sprecher ◽  
Yan Shaefer ◽  
...  

1997 ◽  
Vol 2 (1) ◽  
pp. 2-6
Author(s):  
Qasim H. Wasti ◽  
Sonia Toussaint ◽  
Alfred W. Kopf ◽  
Hideko Kamino ◽  
Nathalie Provost ◽  
...  

Background: A substantial proportion of malignant melanomas arise in preexisting melanocytic nevi. However, the clinical and dermoscopic features of such combination lesions have not been well defined in the literature. Objective: To determine the ability to recognize in thin malignant melanomas the presence or absence of melanocytic nevi based on clinical and/or dermoscopic observations. Methods: Thirty malignant melanomas, less than 1 mm in Breslow thickness, were studied clinically, dermoscopically, and histologically for the presence or absence of features of a melanocytic nevus. Results: The ability to recognize melanocytic nevi within thin malignant melanomas was poor by clinical and dermoscopic examinations, with 30% false negatives and 23% false positives. Conclusion: One cannot depend on clinical and/or dermoscopic observations to rule out a melanocytic nevus within a thin malignant melanoma. Histopathologic study of a small portion of a combined melanocytic neoplasm could lead to the mistaken conclusion that the lesion is entirely a melanocytic nevus or entirely a malignant melanoma. Therefore, when feasible, lesions suspected of being malignant melanomas should be totally excised and step-sectioned throughout.


Sign in / Sign up

Export Citation Format

Share Document